RPL29 and pancreatic neoplasm: The presence of anti-60S ribosomal protein L29 (RPL29) antibody in human serum was shown to inhibit the proliferation of pancreatic cancer cells in various cancers and is believed to be a novel candidate for a prognostic marker for unrespectable pancreatic cancer (Muro et al. 2015).